New carboxylic acid amides, the preparation thereof and their use as pharmaceutical compositions
申请人:Boehringer Ingelheim Pharma GmbH & Co. KG
公开号:US20040077729A1
公开(公告)日:2004-04-22
Carboxylic acid amides of general formula
1
possessing antithrombotic activity and a factor Xa-inhibiting activity. Exemplary are:
(a) 2-(5-amidino-2-hydroxy-phenyl)-N-[3-trifluoromethyl-4-(pyrrolidin-1-yl-carbonyl)phenyl]-3-phenyl-propionamide,
(b) 2-(5-amidino-2-hydroxy-phenyl)-N-[3-trifluoromethyl-4-(pyrrolidin-1-yl-carbonyl)-phenyl]-3-(pyridin-3-yl)-propionamide, and
(c) 2-(5-aminomethyl-2-hydroxy-phenyl)-N-[3-trifluoromethyl-4-(pyrrolidin-l-yl-carbonyl)-phenyl]-3-phenyl-propionamide,
通式1的羧酸酰胺具有抗血栓活性和Xa因子抑制活性。例如:
(a) 2-(5-氨基甲酰基-2-羟基苯基)-N-[3-三氟甲基-4-(吡咯烷-1-基甲酰基)苯基]-3-苯基丙酰胺,
(b) 2-(5-氨基甲酰基-2-羟基苯基)-N-[3-三氟甲基-4-(吡咯烷-1-基甲酰基)苯基]-3-(吡啶-3-基)丙酰胺,
(c) 2-(5-氨甲基-2-羟基苯基)-N-[3-三氟甲基-4-(吡咯烷-1-基甲酰基)苯基]-3-苯基丙酰胺。